Photo of Maritza Davila
D New York Assembly · District 53 On the 2026 ballot

Asm. Maritza Davila

Compare
Total votes
9,713
all sessions
Attendance
86%
1,330 missed
Lower than 84% of chamber peers
With party
99%
of cast votes
Higher than 93% of chamber peers
Bipartisan score
0%
crosses aisle rarely
Lower than 94% of chamber peers
Sponsored
1,510
bills & resolutions
Higher than 87% of chamber peers
Committees
10
assignments
1,510 bills and resolutions

Sponsored bills

Total
1,510
Primary
83
Co-sponsor
1,427
This page
1,510
matching current filters
Co-sponsor A 7560
In committee · New York Assembly · Co-sponsor
Requires the provision of informational materials to child care providers and certain physicians regarding the impacts and dangers of congenital cytomegalovirus infection

Establishes "Elizabeth's law"; requires child care providers to be provided with informational materials on the impacts and dangers of congenital cytomegalovirus infection and the treatments and methods of prevention of cytomegalovirus infection; requires distribution of materials relating to cytomegalovirus by certain physicians.

In committee May 24, 2022 1 co-sponsor
Co-sponsor A 648
In committee · New York Assembly · Co-sponsor
Relates to the statute of limitations for civil actions related to certain sexual offenses committed against a person eighteen years of age or older

Relates to the statute of limitations for civil actions related to certain sexual offenses committed against a person eighteen years of age or older, revives such actions otherwise barred by the existing statute of limitations and grants trial preference to such actions; directs the chief administrator of the courts to promulgate rules for the timely adjudication of certain revived actions.

In committee May 23, 2022 1 co-sponsor
Co-sponsor A 7245
In committee · New York Assembly · Co-sponsor
Preserves access to affordable drugs

Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.

In committee May 23, 2022 1 co-sponsor
Co-sponsor A 3470
In committee · New York Assembly · Co-sponsor
Relates to regulation of billing of facility fees

Relates to regulation of the billing of facility fees; requires notice prior to billing facility fees not covered by a patient's insurance; defines facility fees as those charged by a hospital, facility or provider designed to compensate for operational costs separate from professional fees.

In committee May 18, 2022 1 co-sponsor
Showing 1,381 to 1,390 of 1,510 bills